# Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer

> **NCT04261179** · PHASE4 · UNKNOWN · sponsor: **Anna Cruceta** · enrollment: 30 (estimated)

## Conditions studied

- Head Cancer
- Neck Cancer
- Melanoma
- Breast Cancer

## Interventions

- **DRUG:** Lymphoseek
- **DRUG:** Nanocoll

## Key facts

- **NCT ID:** NCT04261179
- **Lead sponsor:** Anna Cruceta
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03
- **Primary completion:** 2021-02
- **Final completion:** 2021-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04261179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04261179, "Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT04261179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*